| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,762,894 |
|
|
|
Indirect Value
|
$270,797 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,033,691 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-03 |
4 |
OE |
$378.98 |
$416,878 |
D/D |
1,100 |
23,136 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-23 |
4 |
OE |
$378.98 |
$416,878 |
D/D |
1,100 |
24,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-14 |
4 |
D |
$743.78 |
$849,397 |
D/D |
(1,142) |
29,102 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-07-08 |
4 |
AS |
$634.14 |
$742,011 |
D/D |
(1,160) |
23,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-07 |
4 |
D |
$716.09 |
$841,406 |
D/D |
(1,175) |
29,069 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-31 |
4 |
D |
$700.99 |
$829,972 |
D/D |
(1,184) |
29,060 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-04-02 |
4 |
AS |
$483.51 |
$610,672 |
D/D |
(1,248) |
25,161 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-10 |
4 |
D |
$664.34 |
$919,447 |
D/D |
(1,384) |
30,073 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-07 |
4 |
D |
$466.98 |
$688,329 |
D/D |
(1,474) |
7,625 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-12-10 |
4 |
OE |
$555.67 |
$833,505 |
D/D |
1,500 |
31,457 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-03-31 |
4 |
OE |
$399.66 |
$599,490 |
D/D |
1,500 |
30,244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-07 |
4 |
OE |
$399.66 |
$599,490 |
D/D |
1,500 |
30,244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-14 |
4 |
OE |
$381.92 |
$572,880 |
D/D |
1,500 |
30,244 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-31 |
4 |
D |
$751.24 |
$1,140,382 |
D/D |
(1,518) |
29,226 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-22 |
4 |
D |
$476.10 |
$729,385 |
D/D |
(1,532) |
7,567 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-30 |
4 |
D |
$486.91 |
$765,909 |
D/D |
(1,573) |
7,526 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-06 |
4 |
D |
$607.51 |
$993,886 |
D/D |
(1,636) |
26,267 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-11 |
4 |
AS |
$729.76 |
$1,366,821 |
D/D |
(1,862) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-01 |
4 |
D |
$760.35 |
$1,437,062 |
D/D |
(1,890) |
29,354 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,930 |
25,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-07 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-22 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-30 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2021-08-06 |
4 |
OE |
$381.92 |
$763,840 |
D/D |
2,000 |
27,903 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-31 |
4 |
OE |
$381.92 |
$763,840 |
D/D |
2,000 |
30,744 |
0 |
- |
|
158 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
